Close Menu

NEW YORK – Agilent Technologies reported after the close of the market on Monday that its fiscal fourth quarter revenues rose 6 percent year over year, thanks largely to an 8 percent increase in revenues for its crosslab unit and a 5 percent increase in revenues in its diagnostics and genomics business.

For the three months ended Oct. 31, the firm said revenues rose to $1.37 billion from $1.29 billion in Q4 2018, beating the average Wall Street estimate of $1.33 billion. The company said core revenues grew 4 percent year over year in Q4.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

A Minnesota toddler given a gene therapy to treat her spinal muscular atrophy is now walking, according to Newsweek.

NBC Bay Area reports a California lab has been certified to conduct forensic mitochondrial DNA sequencing.

The New York Times reports on how environmental DNA sampling could monitor endangered species.

In Cell this week: proteomic, genomic, and transcriptomic analysis of endometrial cancer; deep neural network learning-based approach to antibiotic discovery; and more.